![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61P 35/00 | (2006.01) |
A61K 45/06 | (2013.01) | ||
A61K 31/5377 | (2006.01) | ||
A61K 31/5377 | (2013.01) | ||
A61K 31/4439 | (2006.01) | ||
A61K 31/4439 | (2013.01) | ||
A61K 45/06 | (2006.01) | ||
A61P 35/00 | (2018.01) | ||
A61P 35/02 | (2018.01) | ||
A61P 43/00 | (2018.01) |
(11) | Number of the document | 3082957 |
(13) | Kind of document | T |
(96) | European patent application number | 14871139.3 |
Date of filing the European patent application | 2014-12-19 | |
(97) | Date of publication of the European application | 2016-10-26 |
(45) | Date of publication and mention of the grant of the patent | 2022-04-06 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2014/071728 |
Date | 2014-12-19 |
(87) | Number | WO 2015/095829 |
Date | 2015-06-25 |
(30) | Number | Date | Country code |
201361919638 P | 2013-12-20 | US |
(72) |
SAHA, Saurabh , US
WELSCH, Dean , US
DECRESCENZO, Gary , US
ROIX, Jeffrey James , GB
|
(73) |
Biomed Valley Discoveries, Inc. ,
4435 Main Street Suite 550, Kansas City, Missouri 64111,
US
|
(54) | CANCER TREATMENTS USING COMBINATIONS OF PI3K/AKT PATHWAY AND ERK INHIBITORS |
CANCER TREATMENTS USING COMBINATIONS OF PI3K/AKT PATHWAY AND ERK INHIBITORS |